These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15700846)

  • 1. Levofloxacin in the treatment of pneumonia in intensive care unit patients.
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sanchez M; Bermejo B;
    J Chemother; 2004 Dec; 16(6):549-56. PubMed ID: 15700846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levofloxacin in the treatment of nosocomial infection in critically ill patients].
    Alvarez Lerma F; Romero Luján JL; Morón Jiménez A; Ortiz López R; Borges Sá M; Grau Cerrato S; Gracia Arnillas MP;
    Rev Esp Quimioter; 2008 Jun; 21(2):83-92. PubMed ID: 18509767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
    Leroy O; Saux P; Bédos JP; Caulin E
    Chest; 2005 Jul; 128(1):172-83. PubMed ID: 16002932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Observational study investigating the use of levofloxacin in ICU patients].
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B;
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levofloxacin in patients in the ICU. Factors influencing the choice of dose and its use in combined therapy].
    Alvarez Lerma F; Palomar M; Olaechea P; Leon C; Sanchez M; Bermejo B;
    Rev Esp Quimioter; 2004 Mar; 17(1):57-63. PubMed ID: 15201925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the intensive care unit.
    Bassetti M; Righi E; Rosso R; Mannelli S; Di Biagio A; Fasce R; Pallavicini FB; Marchetti F; Viscoli C
    Int J Antimicrob Agents; 2006 Dec; 28(6):582-5. PubMed ID: 16979877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients.
    Huang J; Chen EZ; Qu HP; Mao EQ; Zhu ZG; Ni YX; Han LZ; Tang YQ
    Chin Med J (Engl); 2013; 126(10):1826-31. PubMed ID: 23673094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community- and hospital-acquired pneumonia in medical intensive care unit.
    Limthongkul S; Charoenlap P
    J Med Assoc Thai; 1993 Mar; 76(3):129-37. PubMed ID: 8228708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
    Clark LC; Davis CW
    Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia.
    Verhamme KM; De Coster W; De Roo L; De Beenhouwer H; Nollet G; Verbeke J; Demeyer I; Jordens P
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):389-97. PubMed ID: 17385143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
    Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumonia.
    Wasserfallen JB; Erard V; Cometta A; Calandra T; Lamy O
    Eur Respir J; 2004 Oct; 24(4):644-8. PubMed ID: 15459145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
    Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
    Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.